Home > > > > Report Detail

Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019

Publisher Name :
Date: 30-Jan-2015
No. of pages: 184
Inquire Before Buying

The global preclinical imaging market is estimated to grow at a CAGR of 6.0% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the preclinical imaging market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 8.2% in the next five years.Factors such as increased outsourcing of preclinical research activities to Asia-based CROs by big pharmaceutical and biotechnological companies, owing to low cost of research in these nations; and increased government funding for drug discovery and development activities in economically emerging counties are propelling the growth of the preclinical imaging market in Asia-Pacific region.

The growth of the global preclinical imaging market is driven by factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT; growing acceptance of preclinical imaging as a legitimate drug development tool; and rising volume of preclinical research.In addition, emerging markets offering lucrative growth and departure of major companies from preclinical imaging systems market are creating new growth opportunities for the preclinical imaging systems and reagents manufacturers.Nonetheless, declining NIH (National Institutes of Health) funding for life science research, high implementation cost of preclinical imaging devices, and high cost and data requirements for bringing new imaging technology are the key reasons hampering the growth of preclinical imaging market.

In this report, the preclinical imaging market has been segmented on the basis of modality(covering optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photo acoustic, and magnetic particle imaging systems), by type of reagents  (including nuclear imaging reagents, optical imaging reagents, MRI contrast agents, ultrasound contrast agents and CT contrast agents), and by region (North America, Europe, Asia Pacific, and Rest of the World).The optical imaging systems market is estimated to account for the largest share of the global preclinical imaging systems market in 2014. However, the nuclear imaging systems segment is expected to grow at the highest rate during the forecast period. Factors such as development of technologically advanced hybrid nuclear imaging systems such as PET/MRI and PET/SPECT/CT and rising adoption of these devices in the preclinical research are driving the grow of the preclinical nuclear imaging systems market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of36.2% of the global preclinical imaging market in 2014, followed by Europe. The preclinical imaging market in North America is primarily driven by various factors high volume of preclinical research in this region, easy availability and accessibility of resources (such as radioactive tracers), and rising government funding for research and innovation in Canada.

However,declining funding budgets of the U.S. National Institutes of Health (NIH) for preclinical research studies and recent changes in the Canadian R&D tax credit program are negatively affecting the growth of preclinical imaging market in North America.

The global preclinical imaging market is highly fragmented and competitive with a large number of global and local manufacturers of preclinical imaging systems and reagents. As of 2013, the global preclinical imaging market was dominated by Perkin Elmer, Inc. (U.S.) and Bruker Corporation (U.S.), which together accounted for ~45% share of the market. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the preclinical imaging market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and Porter’s five force model), market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the preclinical imaging systems and reagents market, high-growth regions and their respective drivers, restraints,challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share.Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on preclinical imaging products offered by the top 10 players in the preclinical imaging market. The report analyzes the preclinical imaging market by modality and type of reagent across four geographies

  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, and new product launches in the preclinical imaging market

  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various preclinical systems and reagents across geographies

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the preclinical systems and reagents market

  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the preclinical systems and reagents market

Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Pre-Clinical Imaging Market Definition
1.3 Pre-Clinical Imaging Market Scope
1.3.1 Pre-Clinical Imaging Market Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Breakdown and Data Triangulation
2.4 Research Assumptions

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Attractive Market Opportunities in the Pre-Clinical Imaging Market
4.2 Reagents Markets, By Region (2014)
4.3 Systems, By Region (2014)
4.4 Systems Market, By Modality, (2014–2019)

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market Segmentation, By Modality
5.2.2 Market Segmentation, By Reagent
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Advancements in Molecular Imaging Technologies
5.3.1.2 Growing Acceptance of Pre-Clinical Imaging as A Legitimate Drug Development Tool
5.3.1.3 Increasing Demand for Multi-Modality Imaging Technologies in Pre-Clinical Research
5.3.1.4 Increasing Number of Pre-Clinical Research Activities
5.3.2 Restraints
5.3.2.1 High Implementation Costs of Imaging Systems
5.3.2.2 Reduced Nih Funding for Life Science Research Activities
5.3.2.3 High Cost and Data Requirements for Developing New Imaging Technologies
5.3.3 Opportunities
5.3.3.1 Emerging Markets Offer Lucrative Growth Opportunities for Market Players
5.3.3.2 Major Companies Exiting From the Preclinical Imaging Market is Opening New Growth Avenues for Existing Market Players
5.3.3.3 Integration of Preclinical MRI Systems With Other Imaging Modalities
5.3.3.4 Development of Low-Cost Imaging Devices With High Resolution and Sensitivity
5.3.4 Challenges
5.3.4.1 Technological Limitations of Standalone Pre-Clinical Imaging Modalities
5.3.4.2 Challenges Associated With the Application of Radioisotopes Negatively Affects the Demand of Micro-PET Systems

6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Stakeholders
6.3.2 Key Influencers
6.4 Industry Trends
6.4.1 Rising Focus of Market Players Towards the Development of Hybrid Pre-Clinical Imaging Systems
6.4.2 Increasing Government Funding for Pharmaceutical Research and Development in Emerging Nations
6.5 Porter’s Five Forces Analysis
6.5.1 Threat From New Entrants
6.5.2 Threat From Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry

7 Global Pre-Clinical Imaging Market, By Modality
7.2 Introduction
7.3 Optical Imaging Systems
7.3.1 Bioluminescence/Fluorescence Imaging Systems
7.3.2 Standalone Fluorescence Imaging Systems
7.3.3 Optical + X-Ray/Optical + CT
7.4 Pre-Clinical Nuclear Imaging Systems
7.4.1 Micro-PET Systems
7.4.1.1 Standalone PET Systems
7.4.1.2 PET/CT Systems
7.4.1.3 PET/MRI Systems
7.4.2 Micro-SPECT Systems
7.4.2.1 Standalone SPECT Systems
7.4.2.2 SPECT/CT Systems
7.4.2.3 SPECT/MRI Systems
7.4.3 Trimodality (SPECT/PET/CT) Systems
7.5 Micro-MRI
7.6 Micro-Ultrasound
7.7 Micro-CT
7.8 Pre-Clinical Photoacoustic Imaging Systems
7.9 Pre-Clinical Magnetic Particle Imaging (MPI) Systems

8 Global Pre-Clinical Imaging Market, By Reagents
8.1 Introduction
8.2 Pre-Clinical Optical Imaging Reagents
8.2.1 Bioluminescent Imaging Reagents
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Others
8.2.2 Fluorescent Imaging Reagents
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Others (Natural Fluorescence Molecules Such as Collagen and Elastin)
8.3 Pre-Clinical Nuclear Imaging Reagents
8.3.1 Pre-Clinical PET Tracers
8.3.1.1 Fluorine-18-Based Preclinical PET Tracers
8.3.1.2 Carbon-11-Based Preclinical PET Tracers
8.3.1.3 Copper-64-Based Preclinical PET Tracers
8.3.1.4 Others
8.3.2 Pre-Clinical SPECT Probes
8.3.2.1 Technetium-99m-Based Preclinical SPECT Probes
8.3.2.2 Iodine-131-Based Preclinical SPECT Probes
8.3.2.3 Gallium-67-Based Preclinical SPECT Probes
8.3.2.4 Thallium-201-Based Preclinical SPECT Probes
8.3.2.5 Others
8.4 Pre-Clinical MRI Contrast Agents
8.4.1 Gadolinium-Based Pre-Clinical MRI Contrast Agents
8.4.2 Iron-Based Pre-Clinical MRI Contrast Agents
8.4.3 Manganese-Based Pre-Clinical MRI Contrast Agents
8.5 Pre-Clinical Ultrasound Contrast Agents
8.6 Pre-Clinical CT Contrast Agents
8.6.1 Iodine-Based Pre-Clinical CT Contrast Agents
8.6.2 Barium-Based Pre-Clinical CT Contrast Agents
8.6.3 Gold Nanoparticles
8.6.4 Gastrografin-Based Pre-Clinical CT Contrast Agents

9 Geographic Analysis
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis: Pre-Clinical Imaging Market,  By Key Player, 2013
10.3 Competitive Situation and Trends
10.3.1 New Product Launches and Product Developments
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Geographical Expansions
10.3.4 Mergers and Acquisitions
10.3.5 Other Developments

11 Company Profiles
11.1 Perkinelmer, Inc.
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Key Strategy
11.1.4 Key Developments (2012-2014)
11.1.5 SWOT Analysis
11.2 Bruker Corporation
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Key Strategy
11.2.4 Key Developments (2012–2014)
11.2.5 SWOT Analysis
11.3 Fujifilm Visualsonics, Inc.
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Key Strategy
11.3.4 Key Developments (2012–2014)
11.3.5 SWOT Analysis
11.4 Mediso Ltd.
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Key Strategy
11.4.4 Key Developments (2012–2014)
11.4.5 SWOT Analysis
11.5 Trifoil Imaging
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Key Strategy
11.5.4 Key Developments (2012–2014)
11.6 Mr Solutions Ltd.
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Key Strategy
11.6.4 Key Developments (2012-2014)
11.7 Aspect Imaging
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Key Strategy
11.7.4 Key Developments (2012–2014)
11.8 Biospace Lab S.A.
11.8.1 Business Overview
11.8.2 Product Portfolio
11.8.3 Key Strategy
11.8.4 Key Developments (2012–2014)
11.9 Li-Cor Biosciences
11.9.1 Business Overview
11.9.2 Product Portfolio
11.9.3 Key Strategy
11.9.4 Key Developments (2012-2014)
11.1 Milabs B.V.
11.10.1 Business Overview
11.10.2 Product Portfolio
11.10.3 Key Strategy
11.10.4 Key Developments (2012–2014)

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide*
12.3 Company Developments (2012–2014)
12.3.1 Aspect Imaging
12.3.2 Bruker Corporation
12.3.3 Li-Cor Biosciences
12.3.4 Mediso Ltd.
12.3.5 Milabs B.V.
12.3.6 Perkinelmer, Inc.
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables

Table 1 Pre-Clinical Imaging Systems Market Size, By Modality, 2012–2019 ($Million)
Table 2 Pre-Clinical Imaging Systems Market Size, By Region, 2012–2019 ($Million)
Table 3 Global Optical Imaging Systems Market Size, By Type, 2012–2019 ($Million)
Table 4 Optical Imaging Systems Market Size, By Region, 2012–2019 ($Million)
Table 5 Bioluminescence/Fluorescence Imaging Systems Market Size, By Region, 2012–2014 ($Million)
Table 6 Standalone Fluorescence Imaging Systems Market Size, By Region,  2012–2014 ($Million)
Table 7 Optical + X-Ray/Optical + CT Imaging Systems Market Size, By Region,  2012–2014 ($Million)
Table 8 Global Pre-Clinical Nuclear Imaging Systems Market Size, By Type,  2012–2019 ($Million)
Table 9 Pre-Clinical Nuclear Imaging Systems Market Size, By Region,  2012–2019 ($Million)
Table 10 Global Micro-PET Systems Market Size, By Type, 2012–2019 ($Million)
Table 11 Micro-PET Systems Market Size, By Region, 2012–2019 ($Million)
Table 12 Standalone PET Systems Market Size, By Region, 2012–2019 ($Million)
Table 13 PET/CT Systems Market Size, By Region, 2012–2019 ($Million)
Table 14 PET/MRI Systems Market Size, By Region, 2012–2019 ($Million)
Table 15 Global Micro-SPECT Systems Market Size, By Type, 2012–2019 ($Million)
Table 16 Micro-SPECT Systems Market Size, By Region, 2012–2019 ($Million)
Table 17 Standalone SPECT Systems Market Size, By Region, 2012–2019 ($Million)
Table 18 SPECT/CT Systems Market Size, By Region, 2012–2019 ($Million)
Table 19 Micro-MRI Systems Market Size, By Region, 2012–2019 ($Million)
Table 20 Micro-Ultrasound Systems Market Size, By Region, 2012–2019 ($Million)
Table 21 Micro-CT Systems Market Size, By Region, 2012–2019 ($Million)
Table 22 Pre-Clinical Photoacoustic Imaging Systems Market Size, By Region, 2012–2019 ($Million)
Table 23 Global Pre-Clinical Imaging Reagents Market Size, By Type,  2012–2019 ($Million)
Table 24 Pre-Clinical Imaging Reagents Market Size, By Region, 2012–2019 ($Million)
Table 25 Global Pre-Clinical Optical Imaging Reagents Market Size, By Type,  2012–2019 ($Million)
Table 26 Pre-Clinical Optical Imaging Reagents Market Size, By Region,  2012–2019 ($Million)
Table 27 Global Pre-Clinical Bioluminescent Imaging Reagents Market Size, By Type, 2012–2019 ($Million)
Table 28 Pre-Clinical Bioluminescent Imaging Reagents Market Size, By Region,  2012–2019 ($Million)
Table 29 Pre-Clinical Luciferins Market Size, By Region, 2012–2019 ($Million)
Table 30 Pre-Clinical Proluciferins Market Size, By Region, 2012–2019 ($Million)
Table 31 Pre-Clinical Coelenterazine Market Size, By Region, 2012–2019 ($Million)
Table 32 Other Pre-Clinical Bioluminescent Imaging Reagents Market Size, By Region, 2012–2019 ($Million)
Table 33 Global Pre-Clinical Fluorescent Imaging Reagents Market Size, By Type,  2012–2019 ($Million)
Table 34 Pre-Clinical Fluorescent Imaging Reagents Market Size, By Region,  2012–2019 ($Million)
Table 35 Pre-Clinical Green Fluorescent Proteins Market Size, By Region,  2012–2019 ($Million)
Table 36 Pre-Clinical Red Fluorescent Proteins Market Size, By Region,  2012–2019 ($Million)
Table 37 Pre-Clinical Infrared Dyes Market Size, By Region, 2012–2019 ($Million)
Table 38 Other Pre-Clinical Fluorescent Imaging Reagents Market Size, By Region, 2012–2019 ($Million)
Table 39 Global Pre-Clinical Nuclear Imaging Reagents Market Size, By Type,  2012–2019 ($Million)
Table 40 Pre-Clinical Nuclear Imaging Reagents Market Size, By Region,  2012–2019 ($Million)
Table 41 Global Pre-Clinical PET Tracers Market Size, By Type, 2012–2019 ($Million)
Table 42 Pre-Clinical PET Tracers Market Size, By Region, 2012–2019 ($Million)
Table 43 Fluorine-18-Based Pre-Clinical PET Tracers Market Size, By Region,  2012–2019 ($Million)
Table 44 Carbon-11-Based Pre-Clinical PET Tracers Market Size, By Region,  2012–2019 ($Million)
Table 45 Copper-64-Based Pre-Clinical PET Tracers Market Size, By Region,  2012–2019 ($Million)
Table 46 Other Pre-Clinical PET Tracers Market Size, By Region, 2012–2019 ($Million)
Table 47 Global Pre-Clinical SPECT Probes Market Size, By Type, 2012–2019 ($Million)
Table 48 Pre-Clinical SPECT Probes Market Size, By Region, 2012–2019 ($Million)
Table 49 Technetium-99m-Based Pre-Clinical SPECT Probes Market Size,  By Region, 2012–2019 ($Million)
Table 50 Iodine-131-Based Pre-Clinical SPECT Probes Market Size,  By Region, 2012–2019 ($Million)
Table 51 Gallium-67-Based Pre-Clinical SPECT Probes Market Size,  By Region, 2012–2019 ($Million)
Table 52 Thallium-201-Based Pre-Clinical SPECT Probes Market Size,  By Region, 2012–2019 ($Million)
Table 53 Other Pre-Clinical SPECT Probes Market Size, By Region, 2012–2019 ($Million)
Table 54 Global Pre-Clinical MRI Contrast Agents Market Size,   By Type, 2012–2019 ($Million)
Table 55 Pre-Clinical MRI Contrast Agents Market Size, By Region, 2012–2019 ($Million)
Table 56 Gadolinium-Based Pre-Clinical MRI Contrast Agents Market Size,   By Region, 2012–2019 ($Million)
Table 57 Iron-Based Pre-Clinical MRI Contrast Agents Market Size,   By Region, 2012–2019 ($Million)
Table 58 Manganese-Based Pre-Clinical MRI Contrast Agents Market Size,   By Region, 2012–2019 ($Million)
Table 59 Pre-Clinical Ultrasound Contrast Agents Market Size, By Region,  2012–2019 ($Million)
Table 60 Global Pre-Clinical CT Contrast Agents Market Size, By Type,  2012–2019 ($Million)
Table 61 Pre-Clinical CT Contrast Agents Market Size, By Region, 2012–2019 ($Million)
Table 62 Iodine-Based Pre-Clinical CT Contrast Agents Market Size,   By Region, 2012–2019 ($Million)
Table 63 Barium-Based Pre-Clinical CT Contrast Agents Market Size, By Region, 2012–2019 ($Million)
Table 64 Gold Nanoparticles Pre-Clinical CT Contrast Agents Market Size,   By Region, 2012–2019 ($Million)
Table 65 Gastrografin-Based Pre-Clinical CT Contrast Agents Market Size, By Region, 2012–2019 ($Million)
Table 66 Global Systems and Reagents Market Size, By Region, 2012-2019 ($Million)
Table 67 North America: Pre-Clinical Imaging Market, By Product, 2012-2019 ($Million)
Table 68 North America: Systems Market, By Modality,  2012-2019 ($Million)
Table 69 U.S.: Systems Market, By Modality, 2012-2019 ($Million)
Table 70 North America: Reagents Market, By Type,  2012-2019 ($Million)
Table 71 Europe: Pre-Clinical Imaging Market, By Product, 2012-2019 ($Million)
Table 72 Europe: Systems Market, By Modality,   2012-2019 ($Million)
Table 73 Europe: Reagents Market, By Type, 2012-2019 ($Million)
Table 74 Asia-Pacific: Pre-Clinical Imaging Market, By Product, 2012-2019 ($Million)
Table 75 Asia-Pacific: Systems Market, By Modality,  2012-2019 ($Million)
Table 76 Asia-Pacific: Reagents Market, By Type,  2012-2019 ($Million)
Table 77 RoW: Pre-Clinical Imaging Market, By Product, 2012-2019 ($Million)
Table 78 RoW: Systems Market, By Modality, 2012-2019 ($Million)
Table 79 RoW: Reagents Market, By Reagents, 2012-2019 ($Million)
Table 80 Top 5 New Product Launches and Product Developments, 2012–2014
Table 81 Top 5 Agreements, Partnerships, and Collaborations, 2012–2014
Table 82 Top 5 Geographical Expansions, 2012–2014
Table 83 Mergers and Acquisitions, 2012–2014
Table 84 Top 5 Other Developments, 2012–2014

List of Figures

Figure 1 Research Methodology
Figure 2 Break Down of Supply Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Systems Market: Bottom Up Approach
Figure 4 Systems Market: Top-Down Approach
Figure 5 Reagents Market: Top-Down Approach
Figure 6 Pre-Clinical Imaging Market: Data Triangulation
Figure 7 Global Systems Market, 2014 ($Million)
Figure 8 Global Systems Market, 2014 vs. 2019
Figure 9 Global Reagents Market, 2014 vs. 2019
Figure 10 Global Pre-Clinical Imaging Market, By Region, 2014 ($Million)
Figure 11 Emerging Countries Offering High Growth Opportunities to Players in the Market
Figure 12 North America Commands the Largest Share of the Global Reagents Market
Figure 13 Optical, Nuclear, MRI, & Ultrasound Imaging Systems Command the Largest Share of the Global Systems Market
Figure 14 Over 80% of the Global Pre-Clinical Imaging Systems Market Will Be Dominated By Optical, Nuclear, & MRI Systems in 2019
Figure 15 Pre-Clinical Imaging Market Segmentation
Figure 16 Pre-Clinical Imaging Market Segmentation, By Modality
Figure 17 Pre-Clinical Imaging Reagents Market Segmentation, By Reagent
Figure 18 Drivers, Restraints, Opportunities, & Challenges
Figure 19 Advancements in Molecular Imaging Technologies Boosting the Adoption of These Systems in Pre-Clinical Research Studies
Figure 20 High Cost of Imaging Systems and Reduced Nih Funding Are Restricting the Growth of Pre-Clinical Imaging Market
Figure 21 Emerging Economies Offering High Growth Potential for Pre-Clinical Imaging Market
Figure 22 Technological Limitations of Individual Imaging Modalities is A Key Growth Challenge for Standalone Pre-Clinical Imaging Device Providers
Figure 23 Value Chain of Systems Market
Figure 24 Market Players Prefer Both Direct & Indirect Distribution Strategies
Figure 25 Porter’s Five Forces Analysis, 2014
Figure 26 Pre-Clinical Imaging Systems Market, By Modality, 2014 vs. 2019 ($Million): Nuclear Imaging Systems Market to Grow at the Fastest Rate
Figure 27 The Bioluminescence/Fluorescence Imaging Systems Segment Holds A Major Share of the Pre-Clinical Optical Imaging Systems Market (2014)
Figure 28 The Asia-Pacific Pre-Clinical Optical Imaging Systems Market is Expected to Grow at A High Rate From 2014 to 2019
Figure 29 The Asia-Pacific Pre-Clinical Bioluminescence/Fluorescence Imaging Systems Market is Expected to Grow at A Double Digit Rate During the Forecast Period
Figure 30 The Standalone Fluorescence Imaging Systems Market is Expected to Witness Sluggish Growth in All Geographic Regions
Figure 31 Demand for Optical + X-Ray/Optical + CT Imaging Systems is Expected to Grow Rapidly in the Asia-Pacific Region
Figure 32 The Micro-PET Systems Segment Holds the Largest Share of the Pre-Clinical Nuclear Imaging Systems Market in 2014
Figure 33 North America Covers the Largest Share of the Pre-Clinical Nuclear Imaging Systems Market in 2014
Figure 34 PET/MRI Systems Market is Expected to Grow at A Double-Digit Rate During the Forecast Period
Figure 35 Asia-Pacific is Expected to Outpace the European Micro-PET Systems Market By 2019
Figure 36 North America Will Continue to Dominate the Micro-SPECT Systems Market in the Next Five Years
Figure 37 The Asia-Pacific Micro-MRI Systems Market is Expected to Equal the Market Size of the North American Market By 2019
Figure 38 North America Will Continue to Dominate the Global Micro-Ultrasound Systems Market By 2019
Figure 39 North America Holds the Largest Share of the Global Micro-CT Systems Market in 2014
Figure 40 North America is Expected to Be the Second-Fastest-Growing Market for Pre-Clinical Photoacoustic Imaging Systems After Asia-Pacific During The Forecast Period
Figure 41 Global Reagents Market, 2014 vs. 2019 ($Million): MRI Contrast Agents Market to Grow at the Fastest Rate
Figure 42 Bioluminescent Imaging Reagents Segment Will Continue to Dominate the Pre-Clinical Optical Imaging Reagents Market in the Forecast Period
Figure 43 Asia-Pacific Pre-Clinical Optical Imaging Reagents Market is Expected to Grow at the Highest CAGR in the Next Five Years
Figure 44 Luciferins to Command the Largest Share of Bioluminescent Imaging Reagents Market in 2014
Figure 45 Asia-Pacific Region is Estimated to Witness the Highest Growth Rate in the Bioluminescent Imaging Reagents Market
Figure 46 Infrared Dyes Account for the Largest Share of Pre-Clinical Fluorescent Imaging Reagents Market in 2014
Figure 47 Asia-Pacific and ROW Regions Will Drive the Growth of Pre-Clinical Fluorescent Imaging Reagents Market During the Forecast Period
Figure 48 PET Tracers Will Continue to Dominate the Pre-Clinical Nuclear Imaging Reagents Market in the Next Five Years
Figure 49 North America Accounts for the Largest Share of the Global Pre-Clinical Nuclear Imaging Reagents Market in 2014
Figure 50 Fluorine-18-Based PET Tracers Command the Lion’s Share of Pre-Clinical PET Tracers Market in 2014
Figure 51 Technetium-99m-Based SPECT Probes Command the Lion’s Share of Pre-Clinical SPECT Probes Market in 2014
Figure 52 Gadolinium-Based MRI Contrast Agents Command the Largest Share of Pre-Clinical MRI Contrast Agents Market in 2014
Figure 53 Asia-Pacifica MRI Contrast Agents Market is Estimated to Grow at the Highest Rate During the Forecast Period
Figure 54 North America Accounts for the Major Share of the Pre-Clinical Ultrasound Contrast Agents Market in 2014
Figure 55 Iodine-Based Contrast Agents Hold the Largest Share of Pre-Clinical CT Contrast Agents Market in 2014
Figure 56 Market, By Region, 2014 vs. 2019 ($Million): Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 57 North American Pre-Clinical Imaging Market Snapshot (2014-2019): Growth is Driven By High Adoption of Innovative Technologies
Figure 58 European Pre-Clinical Imaging Market Snapshot (2014-2019): Growth is Driven By Increased Government Funding for Developing European Research Sector
Figure 59 Asia-Pacific Pre-Clinical Imaging Market Snapshot (2014-2019): Growth is Driven By Rising Government Investment in Pharmaceutical R&D
Figure 60 Leading Market Players Adopted New Product Launches as the Key Growth Strategy Over the Last Three Years (2012–2014)
Figure 61 Global Pre-Clinical Imaging Market Share, By Key Player, 2013
Figure 62 Battle for Market Share: New Product Launches is the Key Strategy
Figure 63 Perkinelmer, Inc.: Company Snapshot
Figure 64 Bruker Corporation: Company Snapshot
Figure 65 Fujifilm Holdings Corporation.: Company Snapshot

  • Global Radiation Therapy Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Radiation Therapy Devices market was valued at US$ 5449.1 million in 2023 and is anticipated to reach US$ 7088.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in rec......
  • Global Remanufactured Medical Imaging Device Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Refurbishing of medical device refers to restoring used equipment or systems into a condition of safety and effectiveness comparable to new including actions such as repair, rework, update and replacement of worn parts with original parts. The global Remanufactured Medical Imaging Device market was valued at US$ 2887.7 million in 2023 and is anticipated to reach US$ 4107.3 million by 2030, witnessing a CAGR of 5.1% during The forecast period 2024-2030. GE Healthcare, Siemens ......
  • Global Veterinary Diagnostic Imaging Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Veterinary Diagnostic Imaging market size was valued at US$ 929.6 million in 2023. With growing demand in downstream market, the Veterinary Diagnostic Imaging is forecast to a readjusted size of US$ 1370.9 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Veterinary Diagnostic Imaging market. Veterinary Diagnostic Imaging are expected to show stable gro......
  • Global Advanced Visualization Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Advanced Visualization market: According to our latest research, the global Advanced Visualization market looks promising in the next 5 years. As of 2022, the global Advanced Visualization market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Advan......
  • Global Remanufactured Medical Imaging Device Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Remanufactured Medical Imaging Device market size was valued at US$ 2824.9 million in 2023. With growing demand in downstream market, the Remanufactured Medical Imaging Device is forecast to a readjusted size of US$ 4052.6 million by 2030 with a CAGR of 5.3% during review period. The research report highlights the growth potential of the global Remanufactured Medical Imaging Device market. Remanufactured Medical Imaging Devic......
  • Global Gradient Power Amplifier Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The Gradient Power Amplifier market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gradient Power Amplifier market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report pr......
  • Global Intra-Oral Flat Panel Sensor Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Intra-Oral Flat Panel Sensor market size was valued at US$ 323.2 million in 2023. With growing demand in downstream market, the Intra-Oral Flat Panel Sensor is forecast to a readjusted size of US$ 403.4 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Intra-Oral Flat Panel Sensor market. Intra-Oral Flat Panel Sensor are expected to show stable growth i......
  • Global Medical Linear Accelerator Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Medical Linear Accelerator market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical Linear Accelerator is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Medical Linear Accelerator market. Medical Linear Accelerator are expected to show stable growth in the future market. How......
  • Global Digital Impression Standalone Scanners Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Digital Impression Standalone Scanners market size was valued at US$ 195.7 million in 2023. With growing demand in downstream market, the Digital Impression Standalone Scanners is forecast to a readjusted size of US$ 444.8 million by 2030 with a CAGR of 12.4% during review period. The research report highlights the growth potential of the global Digital Impression Standalone Scanners market. Digital Impression Standalone Scan......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs